Skip to content

Talphera, Inc. TLPH Total Equity

Total Equity at other companies

Baxter International logo
Baxter InternationalBAX
$6.04B-14.7%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$41.62M-80.6%
PTH
Pelthos Therapeutics Inc.PTHS
$35.1M+937%
XOMA Corporation logo
XOMA CorporationXOMA
$92.88M+9.7%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$399.9M+2,054%
Royalty Pharma logo
Royalty PharmaRPRX

Other financials

Income statement

See full
Revenue--100%
Gross profit-$1.9M-52.7%
Operating income-$3.9M-35.4%
Net income-$2.6M+1.4%
EPS (diluted)-$0.10+37.5%

Balance sheet

See full
Cash & equivalents$3.8M-29.0%
Total debt$3.4M-79.7%
Total assets$30.2M+101%

Cash flow

See full
Operating cash flow-$3.4M+2.0%
CapEx-
Free cash flow-$2.3M+42.9%

Valuation

See full
Market cap$53.46M+493%
P/S53,456.6×+53,123×

Profitability

See full
Gross margin-127.7%-136pp
Operating margin-1,451,600%-1,507,145pp
Net margin-1,425,300%-1,471,200pp
FCF margin-5,116.7%-6,779pp

Returns & leverage

See full
Return on equity-118.4%+15.4pp
Debt / equity0.2×
Current ratio5.3×+2.2×

Where this comes from

Reported directly by Talphera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Talphera, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Talphera, Inc.'s total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Talphera, Inc.'s total equity?
Talphera, Inc. (TLPH) reported total equity of $18.48M in Q1 2026.
How has Talphera, Inc.'s total equity changed year-over-year?
Talphera, Inc.'s total equity increased by 230.0% year-over-year, from $5.6M to $18.48M.
What is the long-term trend for Talphera, Inc.'s total equity?
Over 5 years (2020 to 2025), Talphera, Inc.'s total equity has grown at a -21.1% compound annual growth rate (CAGR), from -$55.75M to $17.04M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.